Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-18-001247

Options or other derivatives

  • President and CEO acquired 97,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
KIDRON NADAV President and CEO 2018-01-31 Grant or award · Stock Option (right to buy) +97,000 97,000 D: show line 1 in the form
Loading xslF345X03/f4013118nkidronnadav_oramed.xml…